Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

THRIVE and Non-intubated Thoracic Surgery

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Krækjan er vistuð á klemmuspjaldið
Staða
Styrktaraðilar
Taipei Veterans General Hospital, Taiwan

Lykilorð

Útdráttur

Video assisted thoracic surgery utilizes small instruments to perform complicated thoracic surgeries. This minimally invasive technique leaves small wounds thus facilitate recovery. Traditionally, thoracic surgery required general anesthesia with double lumen endobronchial tube to facilitate one-lung ventilation. However, as anesthesia techniques improve, video assisted thoracic surgery can be achieved with minimal sedation and without intubation. Thoracic surgeries involve excision of lung tissue thus impair post-operative lung function, putting patients at high risk of cardiopulmonary complications. Non-intubate thoracic surgeries can avoid this complication by avoiding general anesthesia and intubation.
Transnasal humidified rapid-insufflation ventilator exchange offers 30-50 L/min oxygen via nasal cannula, thus provide safe and comfortable way of oxygen supplementation. It is useful in intravenous sedated patients since they are prone to hypoxia from respiratory suppression and upper airway obstruction.
This study is a matched case-control study to compare the efficacy and safety of Transnasal humidified rapid-insufflation ventilator exchange in non-intubated thoracic surgery versus double lumen endobronchial tube intubated general anesthesia.

Lýsing

Lung cancer has been a leading cause of death for years. There are more than 10,000 new cases in Taiwan. Delayed discovery of the disease is a reason for high mortality rate. Most cases are discovered after second stage. Early discovery of the disease rely on low dose CT scans. Early stage lung cancer patients are candidates for minimally invasive surgeries. Traditionally thoracomies and video-assisted thoracic surgeries require general anesthesia with double lumen endobronchial tubes. The technique of double lumen intubation and one lung ventilation causes respiratory complications and damage to the trachea, larynx and vocal cords. With the development of single port thoracotomies, anesthesia can be minimized as well. Patients receive an epidural, intercostal or paravertebral nerve block to decrease pain. Minimal anesthetic agents may be given to decrease anxiety or to induce light sedation. Patients does not need to be intubated and can maintain respiratory function and can recover quickly.

Not only can video-assisted thoracic surgery be used in lung tumor treatment, it can also be used to threat esophageal and mediastinal lesions, pneumothorax or as a diagnostic tool. Video-assisted thoracic surgery was shown to decrease acute phase inflammatory reactions, decrease immunosuppression and can be beneficial for tumor treatment.

The intravenous sedation medications used in non-intubate thoracic surgery decrease pain and anxiety. However, many will develop respiratory depression and upper airway obstruction. Also, spontaneous pneumothorax during surgery causes one lung ventilation. Traditional oxygen supply cannot meet the demand of non-intubated thoracic surgery. Transnasal humidified rapid-insufflation ventilator exchange offers 30-70 L/min oxygen via nasal cannula. Its humidified oxygen can decrease discomfort from cold dry gas. It also provides positive pressure to the airway thus decrease airway obstruction.

Our hypothesis is that non-intubated thoracic surgery with transnasal humidified rapid-insufflation ventilator exchange can maintain optimal surgical condition such as maintain arterial oxygen pressure, decrease acute phase reactions, tumor suppression and accelerate recovery after surgery.

Dagsetningar

Síðast staðfest: 07/31/2017
Fyrst lagt fram: 09/04/2017
Áætluð skráning lögð fram: 09/05/2017
Fyrst sent: 09/06/2017
Síðasta uppfærsla lögð fram: 09/05/2017
Síðasta uppfærsla sett upp: 09/06/2017
Raunverulegur upphafsdagur náms: 09/10/2017
Áætlaður aðallokunardagur: 09/09/2018
Áætlaður dagsetningu rannsóknar: 09/09/2018

Ástand eða sjúkdómur

Thoracic Surgery
Oxygenation

Íhlutun / meðferð

Device: THRIVE group

Stig

-

Armhópar

ArmurÍhlutun / meðferð
THRIVE group
Patients receiving non-intubated thoracic surgery for lung nodule resections using intravenous sedation and transnasal humidified rapid-insufflation ventilator exchange
Device: THRIVE group
high flow nasal cannula with humidified oxygen
Double lumen group
Patients receiving non-intubated thoracic surgery for lung nodule resections using general anesthesia and double lumen endobronchial tube

Hæfniskröfur

Aldur hæfur til náms 20 Years Til 20 Years
Kyn sem eru hæf til námsAll
SýnatökuaðferðNon-Probability Sample
Tekur við heilbrigðum sjálfboðaliðum
Viðmið

Inclusion Criteria:

- Lung nodules requiring surgical resection

- Resectable by video-assisted thoracic surgery

Exclusion Criteria:

- ASA class IV or V

- Room air oxygen saturation by pulse oximeter < 90%

- Emergent surgery

- Use of inotropics or vasoconstrictors

- History of nasal surgery or cranial surgery

- Abnormal coagulation profile

- History of spinal surgery or trauma

Útkoma

Aðal niðurstöður ráðstafanir

1. Arterial oxygen pressure [From induction of anesthesia to surgical procedure to end of recovery room observation, duration of six hours.]

Capability of maintaining arterial oxygen pressure > 100 mmHg from arterial blood gas analysis before anesthetic induction, during surgery and in recovery room.

2. Arterial carbon dioxide pressure [From induction of anesthesia to surgical procedure to end of recovery room observation, duration of six hours.]

Capability of maintaining arterial carbon dioxide pressure < 50 mmHg from arterial blood gas analysis before anesthetic induction, during surgery and in recovery room.

3. Duration of stay [From admission to ward to discharge from ward, duration of 5 days to two weeks.]

Duration of stay as in days of admission in the hospital

Aðgerðir vegna aukaatriða

1. Acute phase reaction [From induction of anesthesia to surgical procedure to fifth post-operative day, duration of six days.]

Measure of C-reactive protein from blood sample analysis before anesthetic induction, after tumor resection during surgery, on post-operative day 1, 3 and 5.

2. Interleukins [From induction of anesthesia to surgical procedure to fifth post-operative day, duration of six days.]

Measure of interleukins from blood sample analysis before anesthetic induction, after tumor resection during surgery, on post-operative day 1, 3 and 5.

3. TNF [From induction of anesthesia to surgical procedure to fifth post-operative day, duration of six days.]

Measure of interleukins from blood sample analysis before anesthetic induction, after tumor resection during surgery,

4. Immune cell count [From induction of anesthesia to surgical procedure to fifth post-operative day, duration of six days.]

Measure of Immune cell count from blood sample analysis before anesthetic induction, after tumor resection during surgery,

Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge